A Pharmacokinetic Study of DW6012 (FDC of Dapagliflozin and Sitagliptin) in Healthy Adult Volunteers
Condition:   Healthy Subjects Intervention:   Drug: DW6012 Sponsor:   Dong Wha Pharmaceutical Co. Ltd. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2022 Category: Research Source Type: clinical trials

The Effect of Glimepiride Compared With Sitagliptin as an add-on Therapy to Metformin in Severe Insulin Deficiency Diabetes
Conditions:   Diabetes Mellitus, Type 2;   Severe Insulin Deficient Diabetes Interventions:   Drug: Glimepiride;   Drug: Sitagliptin Sponsors:   Peking University People's Hospital;   Peking University First Hospital;   Jiangsu Province Geriatric Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 23, 2022 Category: Research Source Type: clinical trials